In a letter to the president, he wrote, "I urge the administration to consider what steps can be taken under existing authority to prepare and even begin to use a pathway for generic biologics."
Read the full story here.
If you're interested in networking with other professionals in the field of Biosimilars, join our LinkedIn Group here.
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment